Review Standards
The Biotech Capital Group has stringent review standards which allows us to select only those companies and ideas we believe have a reasonable chance of success. Given the large amount of inquiries to our firm we simply can not accept all those who wish to work with us. In total, the Biotech Capital Group accepts roughly 10% of all companies who present their ideas to our review board.
Review Process
From the minute a business plan or idea is submitted to us, it goes through a rigorous review process before any final decision is made. Our firm takes a holistic approach to reviewing each proposal that is submitted. We take the time and dedicate the resources to fully understand the technology implemented, the overall business plan, the market sectorr and competition, feasability of the research process, valuation of the company, time it will take to get a product to market and general impact the product will have on the biotechnology industry.
If you are interested in possibly working with us, we invite you to submit your company's business plan or executive summary to biotechcapital@gmx.com
